Cargando…
Prediction of infection risk in rheumatoid arthritis patients treated with biologics: are we any closer to risk stratification?
PURPOSE OF REVIEW: There are currently several available biologics for rheumatoid arthritis (RA) with similar efficacy in most trials. A major consideration therefore in choosing a biologic, continues to be safety concerns such as infection. Considerable advances have been made in the understanding...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams And Wilkins
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443047/ https://www.ncbi.nlm.nih.gov/pubmed/30789850 http://dx.doi.org/10.1097/BOR.0000000000000598 |